Goldman Sachs Group Inc Iradimed Corp Transaction History

Goldman Sachs Group Inc

$780 Billion
Q3 2025

A detailed history of Goldman Sachs Group Inc transactions in Iradimed Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 149,801 shares of IRMD stock, worth $12.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

149,801

Previous 143,702 4.24%

Holding current value

$12.6 Million

Previous $8.59 Million 24.07%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$56.19 - $74.27 $342,702 - $452,972	6,099 Added 4.24%	149,801 $10.7 Million
Q2 2025 Aug 14, 2025	SELL	$48.67 - $60.8 $1.25 Million - $1.56 Million	-25,685 Reduced 15.16%	143,702 $8.59 Million
Q1 2025 May 09, 2025	BUY	$51.44 - $62.67 $93,672 - $114,122	1,821 Added 1.09%	169,387 $8.89 Million
Q4 2024 Feb 11, 2025	BUY	$48.3 - $57.35 $512,801 - $608,884	10,617 Added 6.76%	167,566 $9.22 Million
Q3 2024 Nov 14, 2024	BUY	$43.23 - $50.29 $3.37 Million - $3.92 Million	77,956 Added 98.69%	156,949 $7.89 Million

Q2 2024 Aug 13, 2024	BUY	$40.36 - $44.7 $1.84 Million - $2.04 Million	45,712 Added 137.35%	78,993 $3.47 Million
Q1 2024 May 15, 2024	SELL	$41.17 - $47.29 $856,418 - $983,726	-20,802 Reduced 38.46%	33,281 $1.46 Million
Q4 2023 Feb 13, 2024	SELL	$37.31 - $47.47 $74,358 - $94,607	-1,993 Reduced 3.55%	54,083 $2.57 Million
Q3 2023 May 14, 2024	BUY	$43.28 - $50.3 $86,257 - $100,247	1,993 Added 3.69%	56,076 $2.49 Million
Q3 2023 Nov 14, 2023	BUY	$43.28 - $50.3 $394,237 - $458,182	9,109 Added 19.39%	56,076 $2.49 Million
Q2 2023 May 14, 2024	SELL	$38.88 - $50.61 $63,685 - $82,899	-1,638 Reduced 3.37%	46,967 $2.24 Million
Q2 2023 Aug 14, 2023	SELL	$38.88 - $50.61 $63,685 - $82,899	-1,638 Reduced 3.37%	46,967 $2.24 Million
Q1 2023 May 14, 2024	SELL	$28.48 - $42.14 $189,249 - $280,020	-6,645 Reduced 12.03%	48,605 $1.91 Million
Q1 2023 May 11, 2023	SELL	$28.48 - $42.14 $189,249 - $280,020	-6,645 Reduced 12.03%	48,605 $1.91 Million
Q4 2022 May 14, 2024	BUY	$26.9 - $30.58 $247,049 - $280,846	9,184 Added 19.94%	55,250 $1.56 Million
Q4 2022 Feb 13, 2023	BUY	$26.9 - $30.58 $247,049 - $280,846	9,184 Added 19.94%	55,250 $1.56 Million
Q3 2022 May 14, 2024	BUY	$29.42 - $42.25 $254,277 - $365,166	8,643 Added 23.1%	46,066 $1.39 Million
Q3 2022 Nov 10, 2022	BUY	$29.42 - $42.25 $254,277 - $365,166	8,643 Added 23.1%	46,066 $1.38 Million
Q2 2022 May 14, 2024	SELL	$30.15 - $45.79 $502,299 - $762,861	-16,660 Reduced 30.8%	37,423 $1.27 Million
Q2 2022 Aug 15, 2022	BUY	$30.15 - $45.79 $87,977 - $133,615	2,918 Added 8.46%	37,423 $1.27 Million
Q1 2022 May 16, 2022	BUY	$36.01 - $53.14 $729,742 - $1.08 Million	20,265 Added 142.31%	34,505 $1.55 Million
Q4 2021 Feb 14, 2022	SELL	$32.35 - $48.27 $7,472 - $11,150	-231 Reduced 1.6%	14,240 $659,000
Q3 2021 Nov 10, 2021	BUY	$29.5 - $37.21 $426,894 - $538,465	14,471 New	14,471 $486,000

Others Institutions Holding IRMD

# of Institutions

190

Shares Held

6.74M

Call Options Held

Put Options Held

9.5K

View Full List

About IRADIMED CORP

Ticker IRMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 12,565,100
Market Cap $1.06B
Description
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...

More about IRMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Iradimed Corp Transaction History